Matches in Wikidata for { <http://www.wikidata.org/entity/Q88789229> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q88789229 description "artículu científicu espublizáu n'agostu de 2017" @default.
- Q88789229 description "im August 2017 veröffentlichter wissenschaftlicher Artikel" @default.
- Q88789229 description "scientific article published on 17 August 2017" @default.
- Q88789229 description "wetenschappelijk artikel" @default.
- Q88789229 description "наукова стаття, опублікована в серпні 2017" @default.
- Q88789229 name "A Phase I study of the pharmacokinetics, safety and tolerability of a novel tocopheryl phosphate mixture/oxymorphone transdermal patch system" @default.
- Q88789229 name "A Phase I study of the pharmacokinetics, safety and tolerability of a novel tocopheryl phosphate mixture/oxymorphone transdermal patch system" @default.
- Q88789229 type Item @default.
- Q88789229 label "A Phase I study of the pharmacokinetics, safety and tolerability of a novel tocopheryl phosphate mixture/oxymorphone transdermal patch system" @default.
- Q88789229 label "A Phase I study of the pharmacokinetics, safety and tolerability of a novel tocopheryl phosphate mixture/oxymorphone transdermal patch system" @default.
- Q88789229 prefLabel "A Phase I study of the pharmacokinetics, safety and tolerability of a novel tocopheryl phosphate mixture/oxymorphone transdermal patch system" @default.
- Q88789229 prefLabel "A Phase I study of the pharmacokinetics, safety and tolerability of a novel tocopheryl phosphate mixture/oxymorphone transdermal patch system" @default.
- Q88789229 P1433 Q88789229-1C91A4ED-A391-445B-81E7-0EE61F2A5F95 @default.
- Q88789229 P1476 Q88789229-F7B48B40-6D77-4E0E-91EE-A6F0F15B6E17 @default.
- Q88789229 P2093 Q88789229-02E8339E-5096-4F37-BB8B-E5931196F01A @default.
- Q88789229 P2093 Q88789229-3AE40CD1-583F-4D4D-A49D-EA40CEE0E5D9 @default.
- Q88789229 P2093 Q88789229-888B0BA6-0EDB-4414-9077-281A09620A9E @default.
- Q88789229 P2093 Q88789229-AADA65BE-779A-4F72-9B50-13ED89BE78F0 @default.
- Q88789229 P2093 Q88789229-E9FC8AC6-C01E-4EFF-AF9D-E144C2481D90 @default.
- Q88789229 P304 Q88789229-7C952A3A-2997-415A-A0D8-E41B2AC2502E @default.
- Q88789229 P31 Q88789229-740EA5E7-EF0F-446F-90C8-C88C233E081A @default.
- Q88789229 P356 Q88789229-7D6B584C-22BF-4DC1-A04C-9D58BC01BE52 @default.
- Q88789229 P433 Q88789229-C58AE7B2-9DFD-41DD-9B97-54DC24B1AB82 @default.
- Q88789229 P478 Q88789229-442BACC9-3C88-46DA-A130-557161C79292 @default.
- Q88789229 P577 Q88789229-69C63453-3446-4023-9CD7-A4234EB93271 @default.
- Q88789229 P698 Q88789229-6A8903CD-8D9D-44F5-A39B-C07D5B9BCB34 @default.
- Q88789229 P921 Q88789229-0B6A772D-AAC7-4C1B-88A0-E9D4B159A7EF @default.
- Q88789229 P356 PMT-2017-0032 @default.
- Q88789229 P698 28814158 @default.
- Q88789229 P1433 Q26842817 @default.
- Q88789229 P1476 "A Phase I study of the pharmacokinetics, safety and tolerability of a novel tocopheryl phosphate mixture/oxymorphone transdermal patch system" @default.
- Q88789229 P2093 "Alisha J Smith" @default.
- Q88789229 P2093 "Janakan Krishnarajah" @default.
- Q88789229 P2093 "Lee S Simon" @default.
- Q88789229 P2093 "Paul D Gavin" @default.
- Q88789229 P2093 "Thomas Schlagheck" @default.
- Q88789229 P304 "499-512" @default.
- Q88789229 P31 Q13442814 @default.
- Q88789229 P356 "10.2217/PMT-2017-0032" @default.
- Q88789229 P433 "6" @default.
- Q88789229 P478 "7" @default.
- Q88789229 P577 "2017-08-17T00:00:00Z" @default.
- Q88789229 P698 "28814158" @default.
- Q88789229 P921 Q323936 @default.